[Memorandum to Presidential Advisory Council on HIV and AIDS Research Committee Members from Bruce G. Weniger]
Incentives and Disincentives for Vaccine Development: A Biotech Perspective Liability * Due to liability concerns many companies have focused mainly on therapies for seropositive patients, rather than vaccine. * An insurance fund sponsored by the Federal Government similar to one for pediatric vaccines could be enacted to encourage companies to pursue development of AIDS vaccines. Page 6
About this Item
- Title
- [Memorandum to Presidential Advisory Council on HIV and AIDS Research Committee Members from Bruce G. Weniger]
- Author
- Weniger, Bruce
- Canvas
- Page 6
- Publication
- 1997-01-10
- Subject terms
- memorandums
- Series/Folder Title
- Government Response and Policy > Presidential > Clinton Administration > Presidential Advisory Council on HIV and AIDS (U.S.) (PACHA) > Meetings and correspondence
- Item type:
- memorandums
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0495.212
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0495.212/11
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0495.212
Cite this Item
- Full citation
-
"[Memorandum to Presidential Advisory Council on HIV and AIDS Research Committee Members from Bruce G. Weniger]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0495.212. University of Michigan Library Digital Collections. Accessed June 12, 2025.